Epilepsy Clinical Trials in Palo Alto, California

5 studies are recruiting for epilepsy in Palo Alto, California right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Safety, Tolerability, and Preliminary Efficacy of Low-intensity Focused Ultrasound Neuromodulation in Patients With Drug-resistant Epilepsy

    This will be a prospective, open-label, single-arm, multi-center, pilot study to evaluate the safety, tolerability, and preliminary efficacy of low-intensity focused ultrasound (LIFU) neuromodulation using NaviFUS System in patients with drug-resistant unilateral or bilateral temporal lobe epilepsy…

    Stage
    Phase 1
    Ages
    18 and older
    Site
    Stanford University School of Medicine, Palo Alto, California
    Locations
    3 in total
    Run by
    NaviFUS Corporation

    See if you can join NCT06388707 on ClinicalTrials.gov

  2. Diagnosing Epilepsy To EffeCT Change

    The purpose of this research is to address the challenges of diagnosing and long-term management of epilepsy in participants whose seizures are not well captured by standard electroencephalography (EEG) tests and who cannot use or are not able to use more standard monitoring techniques. This resear…

    Stage
    Not phased
    Ages
    18 to 75
    Site
    Stanford, Palo Alto, California
    Locations
    21 in total
    Run by
    Epiminder America, Inc.

    See if you can join NCT07110337 on ClinicalTrials.gov

  3. Diagnosing Epilepsy To EffeCT Change Long-Term Follow-Up

    The purpose of this research is to address the challenges of correctly monitoring, managing, and diagnosing epilepsy in participants whose seizures are not well captured by standard electroencephalography (EEG) tests and who cannot use or are not able to use more standard monitoring techniques. Thi…

    Stage
    Not phased
    Ages
    18 to 75
    Site
    Stanford, Palo Alto, California
    Locations
    18 in total
    Run by
    Epiminder America, Inc.

    See if you can join NCT07110454 on ClinicalTrials.gov

  4. Understanding Ketamine's Dissociative Effects (KD Study)

    The purpose of this study is to understand how ketamine brings about dissociative symptoms.

    Stage
    Phase 1
    Ages
    18 and older
    Site
    Stanford University School of Medicine, Palo Alto, California
    Run by
    Stanford University

    See if you can join NCT04861051 on ClinicalTrials.gov

  5. Stopping TSC Onset and Progression 2B: Sirolimus TSC Epilepsy Prevention Study

    This trial is a Phase II randomized, double-blind, placebo controlled multi-site study to evaluate the safety and efficacy of early sirolimus to prevent or delay seizure onset in TSC infants. This study is supported by research funding from the Office of Orphan Products Division (OOPD) of the US Fo…

    Stage
    Phase 2
    Ages
    0 to 0
    Site
    Stanford University, Palo Alto, California
    Locations
    11 in total
    Run by
    Darcy Krueger

    See if you can join NCT05104983 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.